언어 선택
CD7
CD7 분자 정보
| 영어 이름 | T-cell antigen CD7 | 시판 약물 수 | 0 |
| 임상 약물 수 | 32 | 표적 별명 | T-cell antigen CD7，GP40，CD7，TP41，CD7 Molecule，T-Cell Leukemia Antigen，T-Cell Surface Antigen Leu-9，CD7 Antigen (P41)，P41 Protein，CD7 Antigen，LEU-9，Tp40，Antigens， CD7 |
| 최고 연구 개발 단계 | Phase 2 Clinical | ||
| 영어 이름 | T-cell antigen CD7 |
| 표적 별명 | T-cell antigen CD7，GP40，CD7，TP41，CD7 Molecule，T-Cell Leukemia Antigen，T-Cell Surface Antigen Leu-9，CD7 Antigen (P41)，P41 Protein，CD7 Antigen，LEU-9，Tp40，Antigens， CD7 |
| 시판 약물 수 | 0 |
| 임상 약물 수 | 32 |
| 최고 연구 개발 단계 | Phase 2 Clinical |
CD7 제품 목록
- 속성
Protein (19)Antibody (1)Cell Grade Beads (1)Cell (1)
- 제품 라이브러리
온라인 (22)
- 종
Human (16)Mouse (2)Rabbit (1)Cynomolgus (3)
- 태그
Llama IgG Fc Tag (1)His Tag (12)His Tag & Avi Tag (2)Fc Tag & Avi Tag (2)Fc Tag (2)- (3)
- 마커
Unconjugated (6)FITC Labeled (2)Biotin-labeled (5)PE Labeled (2)AF488 Labeled (2)APC Labeled (2)- (2)AF647 Labeled (1)
총 수량22
- 1
- 2
- 3
CD7분자 배경
T-cell antigen CD7 (CD7) is also known as GP40, LEU-9, TP41 and Tp40. CD7 is a protein that in humans is encoded by the CD7 gene, this gene encodes a transmembrane protein which is a member of the immunoglobulin superfamily. CD7 has been shown to interact with PIK3R1. This protein is found on thymocytes and mature T cells. It plays an essential role in T-cell interactions and also in T-cell/B-cell interaction during early lymphoid development.
CD7분자 별명
CD7,GP40,TP41,LEU-9,Tp40
항체 프로젝트 거래 플랫폼
| 프로젝트 이름 | 프로젝트 단계 | 분자 유형 | 분자 출처 | 질병 영역 | 적응증 |
|---|---|---|---|---|---|
| CD7 VHH - 01 | Lead | Monoclonal | Nanobody | Hematological Malignancy | Non-hodgkin lymphoma |
임상 약물 정보
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| Anti-CD7 and anti-CD19 chimeric antigen receptor T cell therapy | GC-197 | Phase 2 Clinical | Gracell Biotechnologies (Shanghai) Co Ltd | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 상세 |
| CLL1/CD33/CD38/CD7 CAR-T cell therapy | Phase 2 Clinical | Guangzhou Bio-Gene Technology Co Ltd | Leukemia, Myeloid, Acute | 상세 | |
| BEAM-201 | BEAM-201 | Phase 2 Clinical | Beam Therapeutics Inc | Leukemia, Lymphoid; Leukemia, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 |
| SupCD7 CART cells therapy (Institute Of Hematology & Blood Diseases Hospital) | Phase 2 Clinical | Institute Of Hematology & Blood Diseases Hospital | Leukemia, Myeloid, Acute; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 | |
| CD7-specific CAR-T Cell therapy(Taihe Chunyu Biotechnology) | Phase 2 Clinical | Hebei Tahoe Chunyu Biotechnology Co Ltd | Hematologic Neoplasms; Lymphoma; Lymphoma, T-Cell | 상세 | |
| CD7 CAR-T cell therapy(The General Hospital Of Western Theater Command) | Phase 2 Clinical | The General Hospital Of Western Theater Command | Leukemia | 상세 | |
| CD5/CD7-Specific CAR-T Cells therapy(Essen Biotech) | BAH246; BAH-246; EB-BH2026 | Phase 2 Clinical | Essen Biotech | Central Nervous System Diseases; Leukemia, Prolymphocytic, T-Cell; Leukemia, T-Cell; Lymphoma, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 |
| Autologous and Donor-derived CD7 CAR-T Therapy(Beijing GoBroad Hospital) | Phase 2 Clinical | Beijing GoBroad Hospital | Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 | |
| CD7-CAR-T Cells Therapy | CD7-CART01 | Phase 2 Clinical | Bambino Gesu Hospital And Research Institute | Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 |
| RD-13 | RD13-02; RD 13 02; RD-13; RD-13-01; CTD-401; CTD-402 | Phase 2 Clinical | Nanjing Bioheng Biotech Co Ltd | Anemia, Aplastic; Diabetes Mellitus, Type 1; Hematologic Diseases; Hematologic Neoplasms; Lymphoma, Extranodal NK-T-Cell; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 |
| Humanized CD7 CAR-T cells | Phase 2 Clinical | The First Affiliated Hospital Of Soochow University | Lymphoma, T-Cell | 상세 | |
| Soficabtagene Geleucel | WU-CART-007 | Phase 2 Clinical | Wugen Inc | Angioimmunoblastic T-cell Lymphoma; Enteropathy-Associated T-Cell Lymphoma; Leukemia, Myeloid, Acute; Leukemia, Prolymphocytic, T-Cell; Leukemia, T-Cell; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Mycosis Fungoides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sezary Syndrome | 상세 |
| SenL-T7 CAR T Cells (Hebei Senlang Biological) | Senl-T7; Senl-T-7; SENL-101 | Phase 2 Clinical | Hebei Senlang Biological Technology Co Ltd | Leukemia, T-Cell; Lymphoma, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; T lymphoblastic lymphoma | 상세 |
| PA3-17 | PA3-17 | Phase 2 Clinical | Persongen Biotherapeutics (Suzhou) Co Ltd | Hematologic Neoplasms; Leukemia, T-Cell; Lymphoma; Lymphoma, T-Cell; T lymphoblastic lymphoma | 상세 |
| CD7 CAR-T cell therapy (Hebei Senlang Biotechnology) | Phase 2 Clinical | Hebei Senlang Biological Technology Co Ltd | Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 | |
| Anti-CD7 CAR T-cell therapy (Yake Biotechnology) | Phase 2 Clinical | Shanghai YaKe Biotechnology Co Ltd | Anemia, Aplastic; Autoimmune Diseases; Bone Marrow Failure Disorders; Colitis, Ulcerative; Crohn Disease; Dermatomyositis; Hematologic Diseases; Leukemia; Leukemia, T-Cell; Lymphoma; Lymphoma, T-Cell; Neoplasms; Osteochondrodysplasias; Still's Disease, Adult-Onset | 상세 | |
| CD7.CAR/28zeta CAR T cells | Phase 1 Clinical | Baylor College Of Medicine | Angioimmunoblastic T-cell Lymphoma; Leukemia, Prolymphocytic; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Mycosis Fungoides; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sezary Syndrome | 상세 | |
| GC-027 | GC-027 | Phase 1 Clinical | Gracell Biotechnologies (Shanghai) Co Ltd | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 |
| UTAA-07 | UTAA-07; UTAA07 | Phase 1 Clinical | Persongen Biotherapeutics (Suzhou) Co Ltd | Hematologic Neoplasms | 상세 |
| JY-008 | JY008; JY-008 | Phase 1 Clinical | Institute Of Hematology & Blood Diseases Hospital | Leukemia, Myeloid, Acute; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 |
| Anti CD7 CAR-T cells therapy (Peking University People'S Hospital) | Phase 1 Clinical | Peking University People'S Hospital | Lymphoma, T-Cell, Peripheral; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 | |
| QH-106 | QH106; QH-106 | Phase 1 Clinical | Anhui Provincial Hospital | Leukemia | 상세 |
| Anti-human CD7 CAR-NK cell Therapy(Shanghai General Hospital) | Phase 1 Clinical | Shanghai Jiao Tong University Affiliated First People'S Hospital | Hematologic Neoplasms; Immune System Diseases | 상세 | |
| uCD7 CART cell therapy (Institute Of Hematology & Blood Diseases Hospital) | Phase 1 Clinical | Institute Of Hematology & Blood Diseases Hospital | Leukemia, Myeloid, Acute; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 | |
| VGO-Cs01p | VGO-Cs01p | Phase 1 Clinical | Shanghai Vitalgen BioPharma Co Ltd | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 상세 |
| MB-107(March Biosciences) | MB-107(March Biosciences) | Phase 1 Clinical | March Biosciences Inc | Lymphoma, T-Cell; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 |
| Anti-CD7 Chimeric Antigen Receptor T-Cell therapy(Bioceltech Therapeutics) | BT-007 | Phase 1 Clinical | Bioceltech Therapeutics Ltd, Gracell Biotechnologies (Shanghai) Co Ltd | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 |
| BE CAR-7 | BE-CAR-7 | Phase 1 Clinical | Great Ormond Street Hospital For Children Nhs Foundation Trust | Leukemia, Prolymphocytic, T-Cell; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 |
| Anti-CD7 CAR-T cell Therapy (Shanghai Jiao Tong University Affiliated First People'S Hospital) | Phase 1 Clinical | Shanghai Jiao Tong University Affiliated First People'S Hospital | Angioimmunoblastic T-cell Lymphoma; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 | |
| Anti-CD19/CD7 UCAR-T cell therapy (Gracell) | GC-502 | Phase 1 Clinical | Gracell Biotechnologies (Shanghai) Co Ltd | Lymphoma, Non-Hodgkin; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 상세 |
| CD7 CARvac T cell therapy (iCell Gene Therapeutics) | Phase 1 Clinical | Icell Gene Therapeutics (Int'L) Ltd | Lymphoma, T-Cell; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 | |
| PCART7-CD3 | PCART7-CD3 | Clinical | National University Of Singapore | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 상세 |
제품 리뷰
A***e2026-06-05
1사람들이 좋아합니다We used CD7 for our SPR assays. The antigen was of good quality, well-behaved, and arrived quickly for our urgent need. I appreciate Acro's suite of QC data provided with each antigen. We appreciate Acro as a reliable source for our protein needs.- J***n2023-06-16 1사람들이 좋아합니다We ordered some Human CD7 Protein and I was whole heartedly impressed with the packaging and support from Acro when I requested some information.
- 분자 정보
- 제품 목록
- 제품 리뷰
- 임상 약물 정보
공유하기:
온라인 메시지
문의하기
전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호